— Know what they know.
Not Investment Advice
Also trades as: MOLN.SW (SIX) · $vol 0M · 0QXX.L (LSE) · $vol 0M · MLLCF (OTC) · $vol 0M

MOLN NASDAQ

Molecular Partners AG
1W: -9.1% 1M: -3.9% 3M: -2.2% YTD: -7.3% 1Y: +5.4% 3Y: -20.2% 5Y: -80.0%
$3.91
+0.00 (+0.00%)
 
Weekly Expected Move ±9.2%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $146.7M mcap · 37M float · 0.012% daily turnover · Short 25% of daily vol

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
$0 +100.0% ▲
Operating Income
-$58M +5.1% ▲
Net Income
-$62M -14.1% ▼
EPS (Diluted)
$-1.65 -3.8% ▼
EBITDA
-$59M -15.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$9M$190M$7M$5M$0
YoY Growth-0.1%+1931.7%-96.3%-29.4%-100.0%
Cost of Revenue$56M$51M$48M$48M$0
Gross Profit-$46M$139M-$41M-$43M$0
Gross Margin-497.2%73.2%-579.8%-855.8%—
R&D Expenses$56M$51M$49M$49M$40M
SG&A Expenses$17M$22M$19M$17M$15M
Operating Expenses$73M$73M$20M$19M$58M
Operating Income-$63M$117M-$61M-$61M-$58M
Operating Margin-679.7%61.5%-868.3%-1231.7%—
Interest Expense$608K$648K$49K$25K$18K
Income Before Tax-$64M$118M-$62M-$54M-$62M
Tax Expense$2K$0$0$2K$2K
Net Income-$64M$118M-$62M-$54M-$62M
Net Margin-683.7%62.2%-880.7%-1087.4%—
EPS (Diluted)$-2.06$3.54$-1.89$-1.59$-1.65
EBITDA-$61M$119M-$60M-$52M-$59M
Shares Outstanding31M33M33M34M37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms